PMEF
MED icon

Point72 Middle East FZE’s Medifast MED Stock Holding History

Point72 Middle East FZE’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,525
Closed -$114K – 1726
2023
Q3 		$114K Buy
+1,525
New +$135K ﹤0.01% 1120
2023
Q2 		– Sell
-985
Closed -$102K – 1870
2023
Q1 		$102K Buy
985
+491
+99% +$54.4K ﹤0.01% 1124
2022
Q4 		$57K Buy
+494
New +$57.5K ﹤0.01% 1418

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Middle East FZE's MED Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Medifast (MED) in Q4 2023, closing a stake of 1,525 shares — an estimated $114K sold.

Point72 Middle East FZE first reported a position in MED in Q4 2022 and held it in 3 quarters. The position peaked at $114K in Q3 2023. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 1,525 Medifast shares in Q4 2023, an estimated $114K.
  • Point72 Middle East FZE first reported a position in Medifast in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Medifast position peaked at $114K in Q3 2023.
  • 216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.